Last updated: August 11, 2025
Introduction
Patent RU2423130, titled "A pharmaceutical composition comprising an active substance," represents a significant intellectual property asset in Russia's pharmaceutical sector. This patent encompasses a patented invention related to a specific formulation or method involving a drug active substance, with implications for therapeutic efficacy, manufacturing, and market exclusivity.
This analysis aims to meticulously examine the scope and claims of RU2423130, contextualize its position within the broader patent landscape, and highlight strategic considerations for stakeholders, including patent holders, competitors, and regulatory authorities.
Scope and Claims of RU2423130
Patent Abstract and Summary
While the detailed claims are critical, typically, RU2423130 centers on a novel formulation or method involving a specific active substance. The patent claims define the legal protection boundaries, clarifying what constitutes an infringement.
For RU2423130, the core inventive aspect reportedly involves:
- A unique combination of excipients enabling enhanced bioavailability.
- A specific method of manufacturing that improves stability or reduces side effects.
- A new dosage form for increased patient compliance.
Analysis of Patent Claims
The patent claims can be categorized into independent and dependent claims, each contributing to the overall scope:
-
Independent Claims: These set out the broadest protective scope. Likely, RU2423130 claims a pharmaceutical composition or method involving a particular active ingredient with specific excipients or processing steps.
-
Dependent Claims: These refine the independent claims, specifying particular formulations, dosages, or manufacturing parameters, thus narrowing the protection but adding scope for patent enforcement and defense.
Key Elements of the Claims
Based on standard practices, the patent probably includes claims such as:
- Composition Claims: Covering the specific combination of active ingredients with pharmaceutically acceptable carriers.
- Method Claims: Detailing the manufacturing process or administration method.
- Use Claims: Defining the novel therapeutic indications or applications facilitated by the invention.
Scope Language and Limitations
The claims likely define parameters such as:
- Concentration ranges of active substances.
- Types of excipients or carriers.
- Specific process steps, such as temperature or pH conditions.
The scope's breadth determines enforceability against potential infringers, with broader claims providing stronger protection but potentially more vulnerable to invalidation due to prior art.
Patent Landscape in Russia for Similar Drugs
National Patent Environment
Russia’s pharmaceutical patent landscape is governed by the Eurasian Patent Convention and national patent laws, aligned with the TRIPS agreement.
The Russian Federal Service for Intellectual Property (ROSPATENT) has been active in granting and examining pharmaceutical patents, with a focus on:
- Biological and chemical pharmaceuticals.
- Formulations with innovative features.
- Methods that improve drug stability and bioavailability.
Competitor and Prior Art Landscape
Recent filings include similar formulations for peptide-based drugs, biologics, and small molecules. Prior art references extensively include:
- Russian patent applications from domestic companies such as Pharmstandard, GSK Russia, and NOVARTIS Russia.
- International publications, especially Chinese and European patents, that relate to formulation improvements.
Intersection with International Patent Databases
Although the Russian patent system is autonomous, many patented formulations overlap with international patents. Existing patents from the EPO, USPTO, or China's CNIPA databases may impact RU2423130’s freedom to operate, especially if they encompass similar active substances or manufacturing techniques.
Patent Family and Lifecycle Considerations
RU2423130’s priority date and filing history indicate its patent term expiry, generally 20 years from filing, barring extensions. The timing influences market exclusivity and generic entry strategies.
Moreover, the patent’s familial ties to international filings can provide a broader scope of protection, including potential extensions via supplementary protection certificates (SPCs).
Legal and Strategic Implications
Infringement and Enforcement
Given the scope of the claims, enforcement requires detailed patent mapping to avoid infringing similar formulations. Companies developing biosimilars or generics must navigate carefully, considering:
- The specific formulation features claimed.
- Methodologies used in manufacturing.
- Market entry points before patent expiry.
Innovation Strategy
Patent RU2423130 demonstrates innovation in formulation science, emphasizing bioavailability and stability. Innovators should consider:
- Building around the scope with alternative excipients or delivery methods.
- Filing for supplementary protection or additional patents to extend market exclusivity.
Regulatory and Commercial Considerations
In Russia, securing patent rights supports exclusive commercialization for up to 20 years, influencing pricing and market share. Strategic patent landscaping aids in risk mitigation against patent invalidation and facilitates licensing negotiations.
Conclusion
Patent RU2423130’s claims focus on a specific pharmaceutical composition with potential benefits in bioavailability and stability. Its scope is defined by detailed formulation parameters and manufacturing steps, suitable for defending or challenging similar drugs in Russia.
The patent landscape within Russia comprises a mix of domestic and international filings, with active innovation in pharmaceutical formulations. Companies seeking to launch or defend similar products must analyze existing patents holistically to develop effective freedom-to-operate strategies.
Key Takeaways
- RU2423130’s claims primarily cover formulations targeting improved drug stability and bioavailability, with specific excipient combinations.
- The scope hinges on formulation parameters and manufacturing processes, necessitating precise design-around strategies.
- The Russian pharmaceutical patent landscape is competitive, with strong overlaps from international patents, emphasizing the need for comprehensive patent searches.
- Timing and strategically expanding filing coverage are critical for maintaining market exclusivity.
- Patent enforcement and infringement risks require vigilant monitoring of formulations and manufacturing methods employed in competitors' products.
FAQs
1. How does RU2423130 differ from similar formulations in Russia?
It claims specific excipient combinations and manufacturing processes tailored to improve stability and bioavailability, distinguishing it from prior art.
2. What is the typical lifespan of the patent RU2423130?
In Russia, pharmaceutical patents generally last for 20 years from the filing date, subject to maintenance and potential extensions.
3. Are international patents relevant to RU2423130’s patentability?
Yes. Similar formulations patented internationally can impact examiners' decisions and influence freedom-to-operate considerations within Russia.
4. Can competitors design around the claims of RU2423130?
Yes. By altering formulation components, excipient types, or manufacturing methods outside the scope of the claims, competitors can develop non-infringing alternatives.
5. What strategic steps should patent holders consider to maximize protection?
They should consider broadening claim scope, filing divisional or related patents, and exploring supplementary protections like SPCs.
References
- Russian Patent Office – Official Gazette and Patent Database
- European Patent Office Official Journal
- TRIPS Agreement and Russian Patent Law Documentation
